Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1993-05-18
1995-02-07
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
564308, A61K 31135
Patent
active
053876121
ABSTRACT:
R(+)-N-propargyl-1-aminoindan, its preparation and use and pharmaceutical compositions containing it. The novel compound was found to be useful for the treatment of human patients for Parkinson's disease, memory disorders, dementia of the Alzheimer type (DAT), depression and the hyperactive syndrome.
REFERENCES:
patent: 3513244 (1970-05-01), Gittos et al.
patent: 4826875 (1989-05-01), Chiesi
Finberg et al., "Modification of Blood Pressure . . . ", Br. J. Pharmac., (1985), 85:541-546.
The Merck Index, Tenth Ed., (1983), pp. 149, 248-249.
Berger-Paskin Tirtsah
Finberg John P. M.
Lerner David
Levy Ruth
Sterling Jeffrey
Burn B. M.
Hollrah Glennon H.
Technion Research and Development Foundation Ltd.
Teva Pharmaceutical Industries Ltd.
White John P.
LandOfFree
Use of the R-enantiomers of N-propargyl-1-aminoindan compounds f does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of the R-enantiomers of N-propargyl-1-aminoindan compounds f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of the R-enantiomers of N-propargyl-1-aminoindan compounds f will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1110748